Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV

By afschroeder • February 5, 2026

Grinspoon SK, Watanabe M, Ribaudo HJ, Bloomfield GS, Fichtenbaum CJ, Umbleja T, Chu SM, Fitch KV, Diggs MR, Zhao S, Looby SE, Currier JS, Aberg JA, Malvestutto CD, Erlandson KM, Martinez E, Asupoto O, Gupta SK, Lopez-Bernaldo de Quiros JC, Nixon D, Bedimo R, Lu MT, Douglas PS, Zanni MV. Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV. Clin Infect Dis. 2026 Feb 4;81(6):e548-e557. doi: 10.1093/cid/ciaf210. PMID: 40281648; PMCID: PMC12501528.

Tags: CVD, HIV, Infectious Diseases, MACE, Publications, REPRIEVE, Women

Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice

Mattos EC, Das Gupta K, Quintanilla D, Hautau H, Ibrahim AS, Singh S. Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice.[...]

The path ahead: Building community between palliative care and infectious disease teams

Karlin D, Vijayan T. The path ahead: Building community between palliative care and infectious disease teams. Clin Microbiol Infect. 2026 Feb 2:S1198-743X(26)00034-0. doi: 10.1016/j.cmi.2026.01.029. Epub[...]

Access to HIV treatment during community-wide flooding: Experiences of people living with HIV and health care workers in Malawi, a mixed methods study

Mphande M, Paneno R, Robson I, Phiri K, Cornell M, van Oosterhout JJ, Eisenman DP, Njala J, Phiri S, Dovel K. Access to HIV treatment[...]